NEWS
News Articles
Georgia State University to study COVID-19 research participation in Black communities
A $1.3 million grant could help Georgia State University play a role in better understanding why predominantly Black communities in Atlanta aren’t participating in COVID-19 research studies. The National Institutes of Health (NIH) awarded an interdisciplinary team at GSU’s School of Public Health the two-year grant through its RADx Underserved Populations (RADx-UP) program “to better understand barriers and motivations…
Read MoreGeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
ATLANTA, GA, November 30, 2020 – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the signing of a Patent and Biological Materials License Agreement (the “License Agreement”) with the National Institute of Allergy and Infectious Diseases (NIAID), part…
Read MoreModerna to submit Covid-19 vaccine to FDA as full results show 94% efficacy
Moderna said Monday that its Covid-19 vaccine continued to deliver strong efficacy results, showing 94% efficacy in the main analysis of its key study. The company said it would immediately seek regulatory clearances in the U.S. and Europe. The milestone suggests that there could be two vaccines against the SARS-CoV-2 virus before the end of 2020. Pfizer…
Read MoreCOVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs
Amgen Inc, UCB SA and Takeda Pharmaceuticals Inc on Monday launched a global trial to identify whether any of three different drugs can reduce the severity of COVID-19 in hospitalized patients by moderating the immune system’s response to the disease. The drugmakers are part of the COVID Research & Development Alliance, a group of more…
Read MoreCMS Announces Comprehensive Strategy to Enhance Hospital Capacity Amid COVID-19 Surge
Today, the Centers for Medicare & Medicaid Services (CMS) outlined unprecedented comprehensive steps to increase the capacity of the American health care system to provide care to patients outside a traditional hospital setting amid a rising number of coronavirus disease 2019 (COVID-19) hospitalizations across the country. These flexibilities include allowances for safe hospital care for eligible…
Read MoreCoronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and…
Read More